Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incannex Healthcare (IXHL) Depreciation & Amortization (CF) (2023 - 2025)

Incannex Healthcare's Depreciation & Amortization (CF) history spans 3 years, with the latest figure at $59000.0 for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) fell 53.17% year-over-year to $59000.0; the TTM value through Dec 2025 reached $181000.0, down 32.71%, while the annual FY2025 figure was $246000.0, 138.83% up from the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 was $59000.0 at Incannex Healthcare, down from $66000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $126000.0 in Q4 2024 and bottomed at -$5000.0 in Q1 2025.
  • The 3-year median for Depreciation & Amortization (CF) is $60000.0 (2025), against an average of $47400.0.
  • The largest annual shift saw Depreciation & Amortization (CF) surged 950.0% in 2024 before it crashed 129.41% in 2025.
  • A 3-year view of Depreciation & Amortization (CF) shows it stood at $12000.0 in 2023, then soared by 950.0% to $126000.0 in 2024, then plummeted by 53.17% to $59000.0 in 2025.
  • Per Business Quant, the three most recent readings for IXHL's Depreciation & Amortization (CF) are $59000.0 (Q4 2025), $66000.0 (Q3 2025), and $61000.0 (Q2 2025).